![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Edsbäcker Staffan
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.43, Iss.12, 2004-01, pp. : 803-821
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapy of Crohn’s disease in childhood
By Beattie R Mark Bremner A Ronald F
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide improves QOL in Crohn's disease
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. :